Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules

Fig. 3

In vitro transfection efficiency of the LPPC/DNA/RBDV complexes. Different concentrations of a RBDV complexes or b IgG1 Fc with 5 μg of DNA and 50 μg of LPPC were transfected into B16-F10 cells, and the cells were observed under a microscope 48 h after transfection. LPPC, which encapsulated with RBDV or IgG1 Fc, were all complexed by PEG

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us